ABSTRACT
PURPOSE: To determine how Meibomian gland (MG) morphology affects MG function by means of gland expression with the effect of treatment. METHODS: Fifteen patients (aged 31.6 ± 13.1 years) from a dry eye clinic diagnosed with MG dysfunction had their 365 lower lid MGs visualised with a slit-lamp biomicroscopy. Using infrared meibography (Oculus K5m), MG length, width and tortuosity were objectively measured. Each MG was expressed and the meibum graded (0=clear fluid, 1=cloudy fluid, 2= particulate fluid, 3=inspissated, or 4 = no expression) to determine its functionality. Participants had functionality repeated each time following a sequence of a warm compress, debridement, and forcible expression after 5 min. RESULTS: Just over 10 % of complete length MGs gave clear expression, while about 5% did not express at all, with most expressed meibum being particulate in nature. In contrast, the majority of partial length glands gave inspissated expression (38 %), with 32 % not expressing at all. No MG of <10 % length expressed. MG gland length was correlated with gland expression (r=-0.507, p < 0.001) and MG tortuosity (r=-0.129, p < 0.001), but not MG width (r=-0.090, p = 0.167). Regardless of MG length, warm compress increased the quality of expression (p < 0.002). Debridement further improved expression in partial MGs (p = 0.003), but not forcible expression (p = 0.529). CONCLUSIONS: Length is the key functional morphology metric of lower lid MGs. Warm compress and massage increase the quality of expression in all, but the shortest glands and patients with partial length glands also benefit from debridement.
Subject(s)
Dry Eye Syndromes , Eyelid Diseases , Meibomian Gland Dysfunction , Dry Eye Syndromes/diagnosis , Eyelid Diseases/diagnosis , Humans , Meibomian Gland Dysfunction/therapy , Meibomian Glands/diagnostic imaging , Meibomian Glands/metabolism , Slit Lamp Microscopy , Tears/metabolismABSTRACT
Age related nuclear (ARN) cataracts in humans take years to form and so experimental models have been developed to mimic the process in animals as a means of better understanding the etiology of nuclear cataracts in humans. A major limitation with these animal models is that many of the biochemical and physiological changes are not typical of that seen in human ARN cataract. In this review, we highlight the work of Frank Giblin and colleagues who established an in vivo animal model that replicates many of the changes observed in human ARN cataract. This model involves exposing aged guinea pigs to hyperbaric oxygen (HBO), which by causing the depletion of the antioxidant glutathione (GSH) specifically in the lens nucleus, produces oxidative changes to nuclear proteins, nuclear light scattering and a myopic shift in lens power that mimics the change that often precedes cataract development in humans. However, this model involves multiple HBO treatments per week, with sometimes up to a total of 100 treatments, spanning up to eight months, which is both costly and time consuming. To address these issues, Giblin developed an in vitro model that used rabbit lenses exposed to HBO for several hours which was subsequently shown to replicate many of the changes observed in human ARN cataract. These experiments suggest that HBO treatment of in vitro animal lenses may serve as a more economical and efficient model to study the development of cataract. Inspired by these experiments, we investigated whether exposure of young bovine lenses to HBO for 15 h could also serve as a suitable acute model of ARN cataract. We found that while this model is able to exhibit some of the biochemical and physiological changes associated with ARN cataract, the decrease in lens power we observed was more characteristic of the hyperopic shift in refraction associated with ageing. Future work will investigate whether HBO treatment to age the bovine lens in combination with an oxidative stressor such as UV light will induce refractive changes more closely associated with human ARN cataract. This will be important as developing an animal model that replicates the changes to lens biochemistry, physiology and optics observed in human ARN cataracts is urgently required to facilitate the identification and testing of anti-cataract therapies that are effective in humans.
Subject(s)
Aging , Cataract/metabolism , Hyperbaric Oxygenation/methods , Lens, Crystalline/chemistry , Optics and Photonics , Animals , Cataract/physiopathology , Cattle , Humans , Lens, Crystalline/diagnostic imaging , Lens, Crystalline/physiology , Slit Lamp MicroscopyABSTRACT
PURPOSE: To report the clinical and confocal findings of a unique case of combined Phialemonium curvatum and Acanthamoeba keratitis and to highlight the role of the prompt diagnosis and specific medical treatment in preserving visual function. METHODS: A case report and literature review. RESULTS: A 54-year-old woman presented with a 3-day history of visual impairment, photophobia, and ocular pain in her right eye. Her best corrected visual acuity was 0.4 Logarithm of the Minimum Angle of Resolution scale, and the slit-lamp examination showed whitish corneal stromal infiltrate with satellite lesions. In vivo confocal microscopy evidenced Acanthamoeba cysts and fungal hyphae that resulted P. curvatum in the culture examination. The intensive medical treatment was started with topical 0.02% polyhexamethylene biguanide, voriconazole 1%, and moxifloxacin hydrochloride 0.5%. Progressive improvement of clinical and confocal pictures was registered with a complete recovery of visual function after 1 month. CONCLUSIONS: This is the first case report of combined P. curvatum and Acanthamoeba keratitis. The fast diagnosis with in vivo confocal microscopy allowed early and intensive specific treatment with recovery of corneal infection.
Subject(s)
Acanthamoeba Keratitis/diagnosis , Ascomycota/isolation & purification , Eye Infections, Fungal/diagnosis , Keratitis/diagnosis , Mycoses/diagnosis , Acanthamoeba Keratitis/drug therapy , Acanthamoeba Keratitis/parasitology , Administration, Ophthalmic , Anti-Bacterial Agents/therapeutic use , Antifungal Agents/therapeutic use , Biguanides/therapeutic use , Disinfectants/therapeutic use , Drug Therapy, Combination , Early Diagnosis , Eye Infections, Fungal/drug therapy , Eye Infections, Fungal/microbiology , Female , Humans , Keratitis/drug therapy , Keratitis/microbiology , Microscopy, Confocal , Middle Aged , Moxifloxacin/therapeutic use , Mycoses/drug therapy , Mycoses/microbiology , Ophthalmic Solutions , Slit Lamp Microscopy , Voriconazole/therapeutic useSubject(s)
Macular Degeneration , Aged , Dietary Supplements , Female , Humans , Macular Degeneration/diagnosis , Macular Degeneration/drug therapy , Patient Education as Topic , Practice Guidelines as Topic , Retina/diagnostic imaging , Retina/pathology , Retinal Drusen , Severity of Illness Index , Slit Lamp Microscopy , Vascular Endothelial Growth Factor A/antagonists & inhibitorsABSTRACT
PURPOSE: The purpose of this study is to report a case of corneal epithelial defects resulting from topical treatment of blepharitis with tea tree oil (TTO). METHODS: A 44-year-old man with a 1 year history of blepharitis non-responsive to eyelid hygiene was found to have signs of Demodex infestation. He was treated with a topical, off-label 50% TTO solution. Shortly afterward, the patient complained of bilateral ocular discomfort. RESULTS: Slit-lamp examination revealed conjunctival injection and a corneal epithelial defect in both eyes. Treatment with lubricant, antibiotic, and steroid eye drops as well as bandage contact lenses was required to facilitate corneal healing. CONCLUSIONS: Topical use of off-label, 50% concentration TTO can result in corneal epithelial defects. Eye care professionals should remain aware of this risk and only use approved, low-concentration TTO products when treating Demodex-related blepharitis.
Subject(s)
Anti-Infective Agents, Local/adverse effects , Blepharitis/drug therapy , Corneal Diseases/chemically induced , Epithelium, Corneal/drug effects , Eye Infections, Parasitic/drug therapy , Mite Infestations/drug therapy , Tea Tree Oil/adverse effects , Adult , Blepharitis/parasitology , Corneal Diseases/diagnosis , Drug-Related Side Effects and Adverse Reactions/diagnosis , Drug-Related Side Effects and Adverse Reactions/etiology , Epithelium, Corneal/pathology , Eye Infections, Parasitic/parasitology , Humans , Male , Mite Infestations/parasitology , Slit Lamp MicroscopyABSTRACT
Objectives: We aimed to evaluate the efficacy of periocular intense pulsed light (IPL) therapy in the treatment of moderate to severe acute blepharitis or blepharoconjunctivitis. Materials and Methods: This was a retrospective study performed in one institution. Eleven patients who received bilateral periocular IPL therapy using an IPL device (E>Eye, ESwin, Paris, France) were retrospectively evaluated. The following findings obtained at baseline and 10 weeks after the treatment were recorded: slit-lamp examinations; symptom scores of the Compression of the Eyelid (COTE) grading system and Ocular Surface Disease Index (OSDI); ocular surface staining with Oxford grading scale (OXFORD) scores; lipid layer thickness (LLT); and non-invasive tear meniscus test (TMH), non-invasive break up time measurement (NIBUT), and meibography performed by using I.C.P. Ocular Surface Analyzer (SBM System, Turin, Italy). Results: Significant improvements in OSDI symptom scores (p<0.0001), LLT (p<0.0001), and meibography (p<0.0001) were obtained at 10 weeks after bilateral periocular IPL therapy. COTE and ocular surface staining scores decreased by 59.72% and 57.14% respectively, while NIBUT and TMH increased by 47.34% and 22.16%, respectively. In parallel to the improvement in OSDI, LLT, and meibography, findings of acute blepharitis or blepharoconjunctivitis improved in slit-lamp examination. There were no adverse effects. Conclusion: Serial IPL therapy improves the clinical signs and symptoms of moderate to severe acute blepharitis or blepharoconjunctivitis, meibomian gland morphology, and secretion quality.
Subject(s)
Blepharitis/therapy , Conjunctivitis/therapy , Intense Pulsed Light Therapy/methods , Tears/metabolism , Acute Disease , Adolescent , Adult , Aged , Blepharitis/diagnosis , Blepharitis/metabolism , Conjunctivitis/diagnosis , Conjunctivitis/metabolism , Female , Humans , Male , Middle Aged , Retrospective Studies , Severity of Illness Index , Slit Lamp Microscopy , Treatment Outcome , Young AdultABSTRACT
PURPOSE: To formulate a xanthan gum-containing linezolid ophthalmic solution (LZD-XG) as a new antibiotic treatment against ocular bacterial infection. METHODS: LZD-XG was prepared and evaluated for its in vitro/in vivo ocular tolerance, in vitro/in vivo antibacterial activity, and in vivo ocular penetration. RESULTS: The optimized LZD-XG exhibited good in vitro/in vivo eye tolerance. A prolonged ocular surface residence time of LZD-XG was observed after topical instillation, and the ocular permeation was significantly better for LZD-XG than fora linezolid (LZD) ophthalmic solution. The in vitro antimicrobial activity was significantly better with LZD-XG than with LZD. In vivo evaluation also confirmed a strong therapeutic treatment effect of LZD-XG, as it significantly improved the clinical symptoms, ameliorated the damage of Staphylococcus aureus to ocular tissues, lowered the colony forming unit counts in the cornea, and decreased the myeloperoxidase activity in the cornea. CONCLUSION: LZD-XG was deemed a viable ophthalmic solution against ocular bacterial infection due to its excellent in vitro and in vivo characterizations.
Subject(s)
Drug Carriers/chemistry , Keratitis/drug therapy , Linezolid/administration & dosage , Ophthalmic Solutions/administration & dosage , Staphylococcal Infections/drug therapy , Administration, Ophthalmic , Animals , Biological Availability , Cornea/drug effects , Cornea/metabolism , Cornea/microbiology , Cornea/pathology , Disease Models, Animal , Humans , Keratitis/diagnosis , Keratitis/microbiology , Keratitis/pathology , Linezolid/pharmacokinetics , Microbial Sensitivity Tests , Ophthalmic Solutions/pharmacology , Permeability , Polysaccharides, Bacterial/chemistry , Rabbits , Slit Lamp Microscopy , Staphylococcal Infections/microbiology , Staphylococcal Infections/pathology , Staphylococcus aureus/drug effectsABSTRACT
ABSTRACT: A 42-year-old Algerian man presented for binocular oblique diplopia, hypersomnolence with drop attacks, bilateral hearing loss, and thoracic pain. He had a right thalamomesencephalic hemorrhage due to an underlying cavernous malformation treated with subtotal surgical resection. On neuro-ophthalmic examination, the patient had a left relative afferent pupillary defect and a right oculosympathetic efferent pupillary defect (i.e., Horner syndrome) in addition to other thalamomesencephalic eye and neurologic signs (right fourth nerve palsy, hearing loss, hemiparesis, and thalamic pain). Clinicians should recognize the localizing value of this unique constellation of mesencephalic afferent and efferent pupillary defects.
Subject(s)
Horner Syndrome/diagnosis , Mesencephalon/pathology , Pupil Disorders/diagnosis , Thalamus/pathology , Adult , Cavernous Sinus/abnormalities , Cavernous Sinus/surgery , Diplopia/diagnosis , Disorders of Excessive Somnolence/diagnosis , Hearing Loss, Bilateral/diagnosis , Horner Syndrome/surgery , Humans , Magnetic Resonance Imaging , Male , Pupil Disorders/surgery , Slit Lamp Microscopy , Tomography, Optical Coherence , Trochlear Nerve Diseases/diagnosis , Vision, BinocularABSTRACT
SIGNIFICANCE: The case report highlights the possible complications of undergoing neck manipulation within a critical time period after intravitreal injection. PURPOSE: This study aimed to describe a case of traumatic hemorrhagic choroidal detachment after cervical manipulation during a chiropractic treatment session. CASE REPORT: A 43-year-old male patient with a history of complex rhegmatogenous retinal detachment repair and recurrent cystoid macular edema presented with decreased vision and sudden pain in the right eye after chiropractic manipulation of the neck, status post-intravitreal injection of triamcinolone, which was performed earlier that day. Vision in the right eye was hand motion and 20/20 in the left eye. IOPs were 8 and 11 mmHg, respectively. Slit lamp examination of the right eye revealed blood-tinged steroid residues in the anterior chamber. There was no view to the posterior pole. Ultrasonography showed a lobulated mass with heterogeneous echogenicity consistent with a large hemorrhagic choroidal detachment. No central kissing was observed. Left eye examination was unremarkable. CONCLUSIONS: With the increasing use of complementary and alternative medicine, a better understanding of potential complications to raise awareness is becoming essential.
Subject(s)
Choroid Hemorrhage/etiology , Manipulation, Chiropractic/adverse effects , Neck Pain/therapy , Adult , Choroid Hemorrhage/diagnostic imaging , Glucocorticoids/therapeutic use , Humans , Intravitreal Injections , Macular Edema/drug therapy , Male , Retinal Detachment/surgery , Slit Lamp Microscopy , Triamcinolone Acetonide/therapeutic use , UltrasonographyABSTRACT
We report a case of severe ocular injury and impaired vision after self-administration of alum. A 56-year-old female administered an alum substance in the left eye and experienced severe corneal thinning, a scar, and decreased vision. The active compounds in the alum substance were analyzed using scanning electron microscopy. When topically administered, alum may cause severe ocular injury. Public awareness, early recognition of the injuries, and timely intervention may prevent permanent ocular damage.
Subject(s)
Adjuvants, Immunologic/toxicity , Alum Compounds/toxicity , Corneal Diseases/chemically induced , Vision Disorders/chemically induced , Adjuvants, Immunologic/chemistry , Alum Compounds/chemistry , Corneal Diseases/diagnosis , Female , Herbal Medicine , Humans , Microscopy, Electron, Scanning , Middle Aged , Self Administration , Slit Lamp Microscopy , Spectrometry, X-Ray Emission , Vision Disorders/diagnosisABSTRACT
Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. UMs are usually initiated by a mutation in GNAQ or GNA11, unlike cutaneous melanomas, which usually harbour a BRAF or NRAS mutation. The annual incidence in Europe and the USA is ~6 per million population per year. Risk factors include fair skin, light-coloured eyes, congenital ocular melanocytosis, ocular melanocytoma and the BAP1-tumour predisposition syndrome. Ocular treatment aims at preserving the eye and useful vision and, if possible, preventing metastases. Enucleation has largely been superseded by various forms of radiotherapy, phototherapy and local tumour resection, often administered in combination. Ocular outcomes are best with small tumours not extending close to the optic disc and/or fovea. Almost 50% of patients develop metastatic disease, which usually involves the liver, and is usually fatal within 1 year. Although UM metastases are less responsive than cutaneous melanoma to chemotherapy or immune checkpoint inhibitors, encouraging results have been reported with partial hepatectomy for solitary metastases, with percutaneous hepatic perfusion with melphalan or with tebentafusp. Better insight into tumour immunology and metabolism may lead to new treatments.
Subject(s)
Melanoma/diagnosis , Melanoma/physiopathology , Uveal Neoplasms/diagnosis , Uveal Neoplasms/physiopathology , Humans , Magnetic Resonance Imaging/methods , Mass Screening/methods , Neoplasm Metastasis/physiopathology , Prognosis , Risk Factors , Slit Lamp Microscopy/methods , Tomography, X-Ray Computed/methodsSubject(s)
Chemical Precipitation , Ciprofloxacin/adverse effects , Cornea/drug effects , Corneal Ulcer/drug therapy , Eye Infections, Bacterial/drug therapy , Moxifloxacin/therapeutic use , Pseudomonas Infections/drug therapy , Administration, Ophthalmic , Aged , Anti-Bacterial Agents/adverse effects , Anti-Bacterial Agents/therapeutic use , Cornea/physiopathology , Drug Substitution , Humans , Male , Ophthalmic Solutions , Slit Lamp MicroscopyABSTRACT
PURPOSE: To investigate the effect of sildenafil on an experimental sodium selenite-induced cataract model in rats. MATERIALS AND METHODS: Twenty-six young Wistar rats were separated into four groups. On postpartum day 10, six rats received only selenite (group 1, selenite-induced cataract), seven rats received selenite and high dose oral sildenafil (group 2, high-dose sildenafil-treated), seven rats received selenite and low dose oral sildenafil (group 3, low-dose sildenafil-treated), and six rats received only saline (group 4, controls). On postpartum day 30, cataract formation was graded and recorded using an operating microscope. The rats were sacrificed, lens tissues were isolated, and serum samples were collected. Nitrite oxide metabolites (NOx), advanced oxidative protein products (AOPP), and total sulfhydryl (TSH) levels were assessed in both serum and lenticular samples. RESULTS: The rats treated with low-dose sildenafil showed lower levels of AOPP and NOx, and the higher levels of TSH than the rats in other experimental groups. Otherwise, the rats treated with high-dose sildenafil, similar to the selenite-induced cataract group, showed higher levels of AOPP and serum NOx than rats in the low-dose sildenafil-treated group. The rats treated with low-dose sildenafil also showed less cataract development than rats in the other experimental groups. CONCLUSION: Low doses (0.7 mg/kg) of oral sildenafil might show a protective effect on cataract development by lowering oxidative stress.
Subject(s)
Cataract/drug therapy , Lens, Crystalline/drug effects , Phosphodiesterase 5 Inhibitors/administration & dosage , Sildenafil Citrate/administration & dosage , Sodium Selenite/toxicity , Trace Elements/toxicity , Administration, Oral , Advanced Oxidation Protein Products/metabolism , Animals , Cataract/chemically induced , Cataract/pathology , Disease Models, Animal , Nitric Oxide/metabolism , Rats , Rats, Wistar , Slit Lamp Microscopy , Sulfhydryl Compounds/metabolismABSTRACT
Purpose: To investigate and compare the effect of warm compresses on meibomian gland dysfunction and Demodex folliculorum blepharitis.Methods: Forty-two subjects (13 males, 29 females; mean age of 56.45 years) enrolled and completed the two-month warm compress treatment study. Three warm compress therapies were compared: Warm face cloth, MGDRx EyeBag® and OPTASETM Moist Heat Mask. Subjects attended for four visits: baseline, two weeks, four weeks, and eight weeks. Subjective symptoms, osmolarity, non-invasive tear break-up time, ocular surface staining, Schirmer I test, meibum expressibility and clarity, and eyelash manipulation and epilation to assess for the presence of Demodex folliculorum, were measured at each visit.Results: Meibomian gland dysfunction, based on a composite score of meibum quality and expressibility, reduced significantly with the MGDRx EyeBag® and the OPTASETM Moist Heat Mask (p < .05). There was no significant difference in efficacy for treating meibomian gland dysfunction between the two devices (p = .29). No improvement in meibomian gland dysfunction was detected with the warm face cloth. Only the OPTASETM Moist Heat Mask significantly reduced the quantity of Demodex folliculorum over eight-weeks of treatment (p = .036, only baseline to week eight significant p = .008). Symptoms and ocular surface staining improved significantly in all three groups (p < .05). There was no significant change observed in osmolarity, non-invasive tear break-up time or Schirmer I test within each group (p > .05, respectively).Conclusion: The MGDRx EyeBag® and the OPTASETM Moist Heat Mask exhibited superior efficacy in treating signs and symptoms of meibomian gland dysfunction, compared to the use of a warm face cloth, over the eight-week period. The OPTASETM Moist Heat Mask demonstrated dual therapeutic abilities, treating both meibomian gland dysfunction and Demodex folliculorum blepharitis. Repeated application of heat for the treatment of meibomian gland dysfunction may continue to present a good home-remedy option for patients.
Subject(s)
Bandages , Blepharitis/therapy , Eye Infections, Parasitic/therapy , Hypothermia, Induced/instrumentation , Meibomian Gland Dysfunction/therapy , Mite Infestations/therapy , Mites , Adult , Aged , Animals , Blepharitis/parasitology , Double-Blind Method , Dry Eye Syndromes/physiopathology , Eye Infections, Parasitic/parasitology , Eyelashes/parasitology , Female , Humans , Male , Meibomian Gland Dysfunction/physiopathology , Middle Aged , Mite Infestations/parasitology , Osmolar Concentration , Prospective Studies , Slit Lamp Microscopy , Surveys and Questionnaires , Tears/physiology , Treatment OutcomeABSTRACT
Glaucoma is a neurodegenerative disease with elevated intraocular pressure as one of the major risk factors. Glaucoma leads to irreversible loss of vision and its progression involves optic nerve head cupping, axonal degeneration, retinal ganglion cell (RGC) loss, and visual field defects. Despite its high global prevalence, glaucoma still remains a major neurodegenerative disease. Introduction of mouse models of experimental glaucoma has become integral to glaucoma research due to well-studied genetics as well as ease of manipulations. Many established inherent and inducible mouse models of glaucoma are used to study the molecular and physiological progression of the disease. One such model of spontaneous mutation is the nee model, which is caused by mutation of the Sh3pxd2b gene. In both humans and mice, mutations disrupting function of the SH3PXD2B adaptor protein cause a developmental syndrome including secondary congenital glaucoma. The purpose of this study was to characterize the early onset nee glaucoma phenotype on the C57BL/6J background and to evaluate the pattern of RGC loss and axonal degeneration in specific RGC subtypes. We found that the B6.Sh3pxd2bnee mutant animals exhibit glaucoma phenotypes of elevated intraocular pressure, RGC loss and axonal degeneration. Moreover, the non-image forming RGCs survived longer than the On-Off direction selective RGCs (DSGC), and the axonal death in these RGCs was independent of their respective RGC subtype. In conclusion, through this study we characterized an experimental model of early onset glaucoma on a C57BL/6J background exhibiting key glaucoma phenotypes. In addition, we describe that RGC death has subtype-specific sensitivities and follows a specific pattern of cell death under glaucomatous conditions.
Subject(s)
Disease Models, Animal , Glaucoma/physiopathology , Ocular Hypertension/physiopathology , Retinal Ganglion Cells/pathology , Animals , Axons/pathology , Cell Count , Cell Survival , Female , Intraocular Pressure/physiology , Male , Mice , Mice, Inbred C57BL , Optic Nerve , Phenotype , Phospholipid Transfer Proteins/genetics , Slit Lamp Microscopy , Tonometry, OcularABSTRACT
PURPOSE: To investigate the effect of Blephadex™ Eyelid Wipes on Demodex mites, ocular microbiota, bacterial lipase, tear film characteristics and ocular comfort after one month of daily use. METHODS: Twenty subjects were randomly assigned to use the Blephadex™ Eyelid Wipes on either eye once daily for 30 days whilst the contralateral eye was left untreated in this observer-masked, within-subject study. Demodex count, eyelid bacterial colony count, Tearscope Plus non-invasive tear break up time (NITBUT), Lipiview® tear film lipid layer thickness and phenol red thread test tear volume were measured at baseline and 30 days. Bacterial lipase was quantified from single bacterial colonies using a glycerol monolaurate assay. Ocular comfort was assessed at both visits using the Ocular Surface Disease Index (OSDI) questionnaire and visual analogue scales (VAS) to capture monocular symptoms of itching, dryness and overall discomfort. RESULTS: Six males and 14 females, median age 63.5 (range 48-76) completed the study. A statistically significant reduction in Demodex count was observed in treated eyes only (median⯱â¯IQR: treated eyes 2⯱â¯3 vs. 0⯱â¯2, ANOVA p = 0.04). Bacterial colony count, lipase production, NITBUT, lipid layer thickness and tear volume remained unchanged (p > 0.05). Overall comfort improved over time in treated eyes only (15⯱â¯32 vs. 10⯱â¯16, p = 0.05). Dryness symptoms significantly reduced in both treated and untreated eyes (23⯱â¯42 vs. 12⯱â¯21 and 23⯱â¯41 vs. 10⯱â¯15, p = 0.02). The OSDI and ocular itch scores remained unchanged (p > 0.05). CONCLUSION: In this pilot study, no changes were observed in ocular microbiota, tear film characteristics or bacterial lipase in eyes treated with Blephadex™ Eyelid Wipes after one month of daily use in this normal healthy population. Although a statistically significant reduction in Demodex count was observed in treated eyes, overall numbers of Demodex were low. A parallel group, placebo-controlled, randomised clinical trial in a population with active blepharitis is warranted to further elucidate these preliminary findings.
Subject(s)
Disinfection/instrumentation , Eyelid Diseases/microbiology , Eyelid Diseases/parasitology , Lipase/metabolism , Microbiota/drug effects , Mite Infestations/drug therapy , Tea Tree Oil/therapeutic use , Aged , Bacteria/enzymology , Coconut Oil/therapeutic use , Colony Count, Microbial , Double-Blind Method , Female , Humans , Male , Middle Aged , Parasite Load , Pilot Projects , Slit Lamp Microscopy , Tears/chemistryABSTRACT
PURPOSE: We present a new device that may aid in glaucoma screening. The vertical cup-to-disc ratio (CDR) obtained from a new electronic mobile device (EMD) was compared with that obtained from a spectral-domain optical coherence tomography. In addition, results from examiner's evaluations were compared with the results mentioned above. METHODS: A single-masked study was performed to evaluate the CDR results from 110 eyes from 110 subjects whose ages ranged between 18 and 60 years (39±13 y old), of whom 66 (60%) were female individuals. Vertical CDR was analyzed 5 times with each device in a single visit and evaluated by 3 different ophthalmologists. The Spearman correlation test and Bland-Altman analysis were used to evaluate the correlation and agreement between methods. RESULTS: The CDR average using spectral-domain optical coherence tomography was 0.47±0.04, whereas the CDR average using EMD was 0.42±0.02. The clinical evaluation resulted in an average of 0.34±0.27. The Spearman test showed a strong correlation between vertical CDR obtained with both devices (r=0.8319; P<0.0001) and between EMD and the examiners (r=0.7156; P>0.001). Bland-Altman analysis showed good agreement between both devices as well as between EMD and the examiners (95% limits of agreement from -0.20 to 0.10 and from -0.15 to 0.30, respectively). CONCLUSIONS: We present a low-cost, reliable EMD that may serve as an alternative to subjectively measuring vertical CDR in face-to-face consultations and hence increase the general public's access to glaucoma screening. This may be especially useful for patients who live in remote areas.
Subject(s)
Diagnostic Techniques, Ophthalmological/instrumentation , Glaucoma, Open-Angle/diagnosis , Optic Disk/pathology , Optic Nerve Diseases/diagnosis , Tomography, Optical Coherence/instrumentation , Adolescent , Adult , Female , Humans , Intraocular Pressure/physiology , Male , Middle Aged , Ophthalmoscopy , Single-Blind Method , Slit Lamp Microscopy , Tonometry, Ocular , Young AdultABSTRACT
PURPOSE: To report 2 patients with colonization of therapeutic contact lens with dematiaceous fungi. METHODS: Case report. RESULTS: The first patient had a retained soft contact lens on an opaque cornea for 4 years with brownish black multiple colonies on the soft contact lens and culture grew Bipolaris spp. The second patient was on therapeutic contact lens for pseudophakic bullous keratopathy for 4 months and developed a brownish colonization of contact lens with unidentified dematiaceous fungi. Both the patients had conjunctivitis but did not develop fungal keratitis. CONCLUSION: Judicious use of therapeutic contact lens is required in agrarian countries with adequate emphasis on strict adherence to the standard protocols and frequent replacement of the lens.
Subject(s)
Contact Lenses, Hydrophilic/microbiology , Eye Infections, Fungal/microbiology , Fungi/isolation & purification , Mycoses/microbiology , Administration, Ophthalmic , Aged , Antifungal Agents/therapeutic use , Drug Therapy, Combination , Eye Infections, Fungal/diagnosis , Eye Infections, Fungal/drug therapy , Humans , Male , Middle Aged , Moxifloxacin/therapeutic use , Mycoses/diagnosis , Mycoses/drug therapy , Natamycin/therapeutic use , Ophthalmic Solutions , Slit Lamp MicroscopyABSTRACT
To describe the successful treatment of epithelial ingrowth using combined surgical excision with intracameral adjuvant 5-fluorouracil (5-FU) followed by Descemet-stripping automated endothelial keratoplasty (DSAEK). A 71-year-old man presented with epithelial ingrowth after clear corneal phacoemulsification. He underwent surgical excision of the membrane together with pars plana vitrectomy, air fluid exchange, and intracameral 5-FU. This treatment resulted in corneal decompensation for which DSAEK was performed 6 months later. Despite interface haze, the postoperative corrected distance visual acuity returned to 20/40 three months after DSAEK. There was no clinical evidence of recurrence of the epithelial ingrowth 9 months after the surgical removal. Intracameral 5-FU can be used in conjunction with surgical excision and subsequent DSAEK to successfully treat epithelial ingrowth.
Subject(s)
Anterior Chamber/pathology , Antimetabolites/therapeutic use , Corneal Diseases/therapy , Descemet Stripping Endothelial Keratoplasty , Epithelium, Corneal/pathology , Fluorouracil/therapeutic use , Aged , Combined Modality Therapy , Cornea/surgery , Corneal Diseases/drug therapy , Corneal Diseases/pathology , Corneal Diseases/surgery , Humans , Male , Phacoemulsification , Slit Lamp MicroscopyABSTRACT
Purpose: We assess the safety and effectiveness of intranasal neurostimulation to promote tear production via the nasolacrimal pathway in subjects with dry eye disease. Methods: A multicenter, randomized, controlled, double-masked pilot study was conducted in adults with dry eye diagnosis and at least one eye with corneal fluorescein staining ≥2 in at least one region or a sum of all regions ≥5 (National Eye Institute grading), basal Schirmer test score ≤10 mm, a cotton-swab stimulated Schirmer score ≥7 mm higher, and an Ocular Surface Disease Index score ≥23. Subjects were randomized to receive active intranasal neurostimulation or sham control intranasal stimulation 4 to 8 times per day. Assessments were scheduled before (unstimulated) and during (stimulated) device application at days 0, 7, 14, 30, and 90. The primary effectiveness endpoint was stimulation-induced change in Schirmer test (with anesthesia) score. Primary safety measure was incidence of device-related adverse events (AEs). Results: Fifty-eight subjects were randomized at nine sites in Australia and New Zealand; 56 completed the 90-day study. Stimulation-induced change in Schirmer score was significantly greater with active intranasal (mean ± SEM, 9.0 ± 2.0) than sham control intranasal stimulation (0.4 ± 0.6; P < 0.001) at day 90. Similar results were observed at days 0, 7, 14, and 30 (P < 0.001). No serious device-related AEs were observed. Mild nosebleed, the most common device-related AE, was reported in five (16.7%) subjects. Conclusions: Intranasal neurostimulation was effective in inducing acute tear production after 90 days of use and generally was well tolerated in subjects with dry eye disease.